TY  - RPRT
TI  - Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer.
AU  - M Karthaus
AU  - Harald Ballo
AU  - Wolgang Abenhardt
AU  - Tilmann Steinmetz
AU  - Thomas Geer
AU  - Jorg Schimke
AU  - Dietrich Braumann
AU  - Rudiger Behrens
AU  - Dirk Behringer
AU  - Manfred Kindler
AU  - Helmut Messmann
AU  - Hans-Peter Boeck
AU  - Roland Greinwald
AU  - Ulrich Kleeberg
PY  - 2005
DO  - 10.1159/000086971
UR  - https://pubmed.ncbi.nlm.nih.gov/16020959/
ID  - 16020959
ER  -